Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
5B0U
DownloadVisualize
BU of 5b0u by Molmil
Crystal structure of the mutated 19 kDa protein of Oplophorus luciferase (nanoKAZ)
Descriptor: Oplophorus-luciferin 2-monooxygenase catalytic subunit
Authors:Tomabechi, Y, Ehara, H, Sekine, S.I, Shirouzu, M.
Deposit date:2015-11-04
Release date:2016-01-13
Last modified:2024-03-20
Method:X-RAY DIFFRACTION (1.71 Å)
Cite:Crystal structure of nanoKAZ: The mutated 19 kDa component of Oplophorus luciferase catalyzing the bioluminescent reaction with coelenterazine
Biochem.Biophys.Res.Commun., 470, 2016
7C03
DownloadVisualize
BU of 7c03 by Molmil
Crystal structure of POLArISact(T57S), genetically encoded probe for fluorescent polarization
Descriptor: POLArISact(T57S)
Authors:Tomabechi, Y, Sakai, N, Shirouzu, M.
Deposit date:2020-04-30
Release date:2021-03-17
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.501 Å)
Cite:POLArIS, a versatile probe for molecular orientation, revealed actin filaments associated with microtubule asters in early embryos.
Proc.Natl.Acad.Sci.USA, 118, 2021
5H09
DownloadVisualize
BU of 5h09 by Molmil
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-ethyl2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-4-methylpentanoate
Descriptor: Tyrosine-protein kinase HCK, ethyl (2~{S})-2-[[4-[4-azanyl-5-(4-phenoxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexyl]amino]-4-methyl-pentanoate
Authors:Tomabechi, Y, Kukimoto-Niino, M, Shirouzu, M.
Deposit date:2016-10-04
Release date:2017-10-04
Last modified:2023-11-15
Method:X-RAY DIFFRACTION (1.945 Å)
Cite:Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen.
Bioorg. Med. Chem., 25, 2017
5H0B
DownloadVisualize
BU of 5h0b by Molmil
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-4-methylpentanoic acid
Descriptor: (2~{S})-2-[[4-[4-azanyl-5-(4-phenoxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexyl]azaniumyl]-4-methyl-pentanoate, Tyrosine-protein kinase HCK
Authors:Tomabechi, Y, Kukimoto-Niino, M, Shirouzu, M.
Deposit date:2016-10-04
Release date:2017-10-11
Last modified:2023-11-15
Method:X-RAY DIFFRACTION (1.651 Å)
Cite:Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen.
Bioorg. Med. Chem., 25, 2017
5H0H
DownloadVisualize
BU of 5h0h by Molmil
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-N,N,4-trimethylpentanamide
Descriptor: (2~{S})-2-[[4-[4-azanyl-5-(4-phenoxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexyl]amino]-~{N},~{N},4-trimethyl-pentanamide, Tyrosine-protein kinase HCK
Authors:Tomabechi, Y, Kukimoto-Niino, M, Shirouzu, M.
Deposit date:2016-10-04
Release date:2017-10-04
Last modified:2023-11-15
Method:X-RAY DIFFRACTION (1.72 Å)
Cite:Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen.
Bioorg. Med. Chem., 25, 2017
5H0E
DownloadVisualize
BU of 5h0e by Molmil
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-4-methylpentanamide
Descriptor: (2~{S})-2-[[4-[4-azanyl-5-(4-phenoxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexyl]amino]-4-methyl-pentanamide, Tyrosine-protein kinase HCK
Authors:Tomabechi, Y, Kukimoto-Niino, M, Shirouzu, M.
Deposit date:2016-10-04
Release date:2017-10-04
Last modified:2023-11-15
Method:X-RAY DIFFRACTION (2.1 Å)
Cite:Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen.
Bioorg. Med. Chem., 25, 2017
5H0G
DownloadVisualize
BU of 5h0g by Molmil
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-N,4-dimethylpentanamide
Descriptor: (2~{S})-2-[[4-[4-azanyl-5-(4-phenoxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexyl]amino]-~{N},4-dimethyl-pentanamide, Tyrosine-protein kinase HCK
Authors:Tomabechi, Y, Kukimoto-Niino, M, Shirouzu, M.
Deposit date:2016-10-04
Release date:2017-10-04
Last modified:2023-11-15
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen.
Bioorg. Med. Chem., 25, 2017
7EG3
DownloadVisualize
BU of 7eg3 by Molmil
Crystal structure of the apoAequorin complex with (S)-HM-daCTZ
Descriptor: (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one, Aequorin-2
Authors:Tomabechi, Y, Shirouzu, M.
Deposit date:2021-03-24
Release date:2021-06-23
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.09 Å)
Cite:Chiral deaza-coelenterazine analogs for probing a substrate-binding site in the Ca2+-binding photoprotein aequorin.
Plos One, 16, 2021
7EG2
DownloadVisualize
BU of 7eg2 by Molmil
Crystal structure of the apoAequorin complex with (S)-daCTZ
Descriptor: (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one, Aequorin-2
Authors:Tomabechi, Y, Shirouzu, M.
Deposit date:2021-03-24
Release date:2021-06-23
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.22 Å)
Cite:Chiral deaza-coelenterazine analogs for probing a substrate-binding site in the Ca2+-binding photoprotein aequorin.
Plos One, 16, 2021
5GV0
DownloadVisualize
BU of 5gv0 by Molmil
Crystal structure of the membrane-proximal domain of mouse lysosome-associated membrane protein 1 (LAMP-1)
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, Lysosome-associated membrane glycoprotein 1, SULFATE ION
Authors:Tomabechi, Y, Ehara, H, Kukimoto-Niino, M, Shirouzu, M.
Deposit date:2016-09-01
Release date:2016-10-12
Last modified:2020-07-29
Method:X-RAY DIFFRACTION (1.5 Å)
Cite:Lysosome-associated membrane proteins-1 and -2 (LAMP-1 and LAMP-2) assemble via distinct modes
Biochem.Biophys.Res.Commun., 479, 2016
5GV3
DownloadVisualize
BU of 5gv3 by Molmil
Crystal structure of the membrane-distal domain of mouse lysosome-associated membrane protein 2 (LAMP-2)
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, Lysosome-associated membrane glycoprotein 2, ZINC ION
Authors:Tomabechi, Y, Ehara, H, Kukimoto-Niino, M, Shirouzu, M.
Deposit date:2016-09-01
Release date:2017-09-06
Last modified:2020-07-29
Method:X-RAY DIFFRACTION (2.096 Å)
Cite:Lysosome-associated membrane proteins-1 and -2 (LAMP-1 and LAMP-2) assemble via distinct modes.
Biochem. Biophys. Res. Commun., 479, 2016
5ZJ6
DownloadVisualize
BU of 5zj6 by Molmil
Crystal structure of HCK kinase complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Descriptor: 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, Tyrosine-protein kinase HCK
Authors:Tomabechi, Y, Kukimoto-Niino, M, Shirouzu, M.
Deposit date:2018-03-19
Release date:2018-06-06
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (1.696 Å)
Cite:Phosphorylated and non-phosphorylated HCK kinase domains produced by cell-free protein expression.
Protein Expr. Purif., 150, 2018
7VSX
DownloadVisualize
BU of 7vsx by Molmil
Crystal structure of QL-nanoKAZ (Reverse mutant of nanoKAZ with L18Q and V27L)
Descriptor: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, QLnK
Authors:Tomabechi, Y, Sekine, S, Shirouzu, M, Takamitsu, H, Satoshi, I.
Deposit date:2021-10-27
Release date:2022-08-24
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (1.698 Å)
Cite:Reverse mutants of the catalytic 19 kDa mutant protein (nanoKAZ/nanoLuc) from Oplophorus luciferase with coelenterazine as preferred substrate.
Plos One, 17, 2022
4WR5
DownloadVisualize
BU of 4wr5 by Molmil
Crystal Structure of GST Mutated with Halogenated Tyrosine (7cGST-1)
Descriptor: GLUTATHIONE, Glutathione S-transferase class-mu 26 kDa isozyme, SULFATE ION
Authors:Akasaka, R, Kawazoe, M, Tomabechi, Y, Ohtake, K, Itagaki, T, Takemoto, C, Shirouzu, M, Yokoyama, S, Sakamoto, K.
Deposit date:2014-10-23
Release date:2015-08-19
Last modified:2023-11-08
Method:X-RAY DIFFRACTION (1.93 Å)
Cite:Protein stabilization utilizing a redefined codon
Sci Rep, 5, 2015
3QHE
DownloadVisualize
BU of 3qhe by Molmil
Crystal structure of the complex between the armadillo repeat domain of adenomatous polyposis coli and the tyrosine-rich domain of Sam68
Descriptor: Adenomatous polyposis coli protein, KH domain-containing, RNA-binding, ...
Authors:Morishita, E.C.J, Murayama, K, Kato-Murayama, M, Ishizuku-Katsura, Y, Tomabechi, Y, Terada, T, Handa, N, Shirouzu, M, Akiyama, T, Yokoyama, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI)
Deposit date:2011-01-25
Release date:2011-11-02
Last modified:2023-11-01
Method:X-RAY DIFFRACTION (2.4 Å)
Cite:Crystal structures of the armadillo repeat domain of adenomatous polyposis coli and its complex with the tyrosine-rich domain of sam68
Structure, 19, 2011
4WR4
DownloadVisualize
BU of 4wr4 by Molmil
Crystal Structure of GST Mutated with Halogenated Tyrosine (7bGST-1)
Descriptor: GLUTATHIONE, Glutathione S-transferase class-mu 26 kDa isozyme, SULFATE ION
Authors:Akasaka, R, Kawazoe, M, Tomabechi, Y, Ohtake, K, Itagaki, T, Takemoto, C, Shirouzu, M, Yokoyama, S, Sakamoto, K.
Deposit date:2014-10-23
Release date:2015-08-19
Last modified:2023-11-08
Method:X-RAY DIFFRACTION (1.6 Å)
Cite:Protein stabilization utilizing a redefined codon
Sci Rep, 5, 2015
4LM5
DownloadVisualize
BU of 4lm5 by Molmil
Crystal structure of Pim1 in complex with 2-{4-[(3-aminopropyl)amino]quinazolin-2-yl}phenol (resulting from displacement of SKF86002)
Descriptor: 2-{4-[(3-aminopropyl)amino]quinazolin-2-yl}phenol, GLYCEROL, Serine/threonine-protein kinase pim-1
Authors:Parker, L.J, Tanaka, A, Handa, N, Honda, K, Tomabechi, Y, Shirouzu, M, Yokoyama, S.
Deposit date:2013-07-10
Release date:2014-02-12
Last modified:2023-12-06
Method:X-RAY DIFFRACTION (2.25 Å)
Cite:Kinase crystal identification and ATP-competitive inhibitor screening using the fluorescent ligand SKF86002.
Acta Crystallogr.,Sect.D, 70, 2014
4LMU
DownloadVisualize
BU of 4lmu by Molmil
Crystal structure of Pim1 in complex with the inhibitor Quercetin (resulting from displacement of SKF86002)
Descriptor: 3,5,7,3',4'-PENTAHYDROXYFLAVONE, GLYCEROL, Serine/threonine-protein kinase pim-1
Authors:Parker, L.J, Tanaka, A, Handa, N, Honda, K, Tomabechi, Y, Shirouzu, M, Yokoyama, S.
Deposit date:2013-07-11
Release date:2014-02-12
Last modified:2023-11-08
Method:X-RAY DIFFRACTION (2.38 Å)
Cite:Kinase crystal identification and ATP-competitive inhibitor screening using the fluorescent ligand SKF86002.
Acta Crystallogr.,Sect.D, 70, 2014
4LL5
DownloadVisualize
BU of 4ll5 by Molmil
Crystal Structure of Pim-1 in complex with the fluorescent compound SKF86002
Descriptor: 6-(4-fluorophenyl)-5-(pyridin-4-yl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole, CALCIUM ION, GLYCEROL, ...
Authors:Parker, L.J, Tanaka, A, Handa, N, Honda, K, Tomabechi, Y, Shirouzu, M, Yokoyama, S.
Deposit date:2013-07-09
Release date:2014-02-12
Last modified:2023-11-08
Method:X-RAY DIFFRACTION (2 Å)
Cite:Kinase crystal identification and ATP-competitive inhibitor screening using the fluorescent ligand SKF86002.
Acta Crystallogr.,Sect.D, 70, 2014
4LUE
DownloadVisualize
BU of 4lue by Molmil
Crystal Structure of HCK in complex with 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (resulting from displacement of SKF86002)
Descriptor: 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, CALCIUM ION, CHLORIDE ION, ...
Authors:Parker, L.J, Tanaka, A, Handa, N, Honda, K, Tomabechi, Y, Shirouzu, M, Yokoyama, S.
Deposit date:2013-07-25
Release date:2014-02-12
Last modified:2023-12-06
Method:X-RAY DIFFRACTION (3.04 Å)
Cite:Kinase crystal identification and ATP-competitive inhibitor screening using the fluorescent ligand SKF86002.
Acta Crystallogr.,Sect.D, 70, 2014
4LUD
DownloadVisualize
BU of 4lud by Molmil
Crystal Structure of HCK in complex with the fluorescent compound SKF86002
Descriptor: 6-(4-fluorophenyl)-5-(pyridin-4-yl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole, CALCIUM ION, CHLORIDE ION, ...
Authors:Parker, L.J, Tanaka, A, Handa, N, Honda, K, Tomabechi, Y, Shirouzu, M, Yokoyama, S.
Deposit date:2013-07-25
Release date:2014-02-12
Last modified:2023-12-06
Method:X-RAY DIFFRACTION (2.85 Å)
Cite:Kinase crystal identification and ATP-competitive inhibitor screening using the fluorescent ligand SKF86002.
Acta Crystallogr.,Sect.D, 70, 2014
5X1D
DownloadVisualize
BU of 5x1d by Molmil
Crystal Structure of T246A-N247A Human CRMP-2 Mutant
Descriptor: Dihydropyrimidinase-related protein 2
Authors:Nitta, R, Tomabechi, Y, Aoki, M, Shirouzu, M.
Deposit date:2017-01-25
Release date:2017-09-20
Last modified:2024-03-20
Method:X-RAY DIFFRACTION (2.2 Å)
Cite:Structural basis for CRMP2-induced axonal microtubule formation
Sci Rep, 7, 2017
5X1A
DownloadVisualize
BU of 5x1a by Molmil
Crystal Structure of Human CRMP-2
Descriptor: Dihydropyrimidinase-related protein 2
Authors:Nitta, R, Tomabechi, Y, Aoki, M, Shirouzu, M.
Deposit date:2017-01-25
Release date:2017-09-20
Last modified:2024-03-20
Method:X-RAY DIFFRACTION (1.821 Å)
Cite:Structural basis for CRMP2-induced axonal microtubule formation
Sci Rep, 7, 2017
5X1C
DownloadVisualize
BU of 5x1c by Molmil
Crystal Structure of Human CRMP-2 without C-terminal Tail
Descriptor: Dihydropyrimidinase-related protein 2
Authors:Nitta, R, Tomabechi, Y, Aoki, M, Shirouzu, M.
Deposit date:2017-01-25
Release date:2017-09-20
Last modified:2024-03-20
Method:X-RAY DIFFRACTION (2.101 Å)
Cite:Structural basis for CRMP2-induced axonal microtubule formation
Sci Rep, 7, 2017
5ZAB
DownloadVisualize
BU of 5zab by Molmil
Crystal structure of cf3-aequorin
Descriptor: (2S)-8-benzyl-2-hydroperoxy-6-(4-hydroxyphenyl)-2-{[4-(trifluoromethyl)phenyl]methyl}imidazo[1,2-a]pyrazin-3(2H)-one, Aequorin-2
Authors:Inouye, S, Tomabechi, Y, Sekine, S.I, Shirouzu, M, Hosoya, T.
Deposit date:2018-02-07
Release date:2018-06-06
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (2.147 Å)
Cite:Slow luminescence kinetics of semi-synthetic aequorin: expression, purification and structure determination of cf3-aequorin.
J. Biochem., 164, 2018

 

123>

217705

PDB entries from 2024-03-27

PDB statisticsPDBj update infoContact PDBjnumon